OCULAR HISTOPLASMOSIS

Insights

This study presents three Ontario residents diagnosed with histoplasmic chorioretinitis. Intravenous amphotericin B treatment improved ocular lesions, suggesting its consideration for this fungal eye infection.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Mycology

Background:

  • Histoplasmic chorioretinitis is an ocular manifestation of disseminated histoplasmosis.
  • Diagnosis can be challenging without definitive fungal proof in the eye.
  • Calcified chest lesions and specific skin tests aid in diagnosis.

Purpose of the Study:

  • To report cases of histoplasmic chorioretinitis in Ontario residents.
  • To evaluate the efficacy and safety of amphotericin B treatment.
  • To highlight the importance of clinical and laboratory findings for diagnosis.

Main Methods:

  • Clinical case reports of three patients.
  • Diagnostic criteria included clinical appearance, chest imaging, and skin testing (tuberculin and toxoplasmin).
  • Treatment administered: intravenous amphotericin B.

Main Results:

  • All three patients showed improvement in ocular lesions after amphotericin B treatment.
  • Transient elevation of blood urea nitrogen was the main side effect.
  • No serious complications were observed with amphotericin B therapy.

Conclusions:

  • Clinical and laboratory findings can support a diagnosis of histoplasmosis even without direct fungal confirmation.
  • Intravenous amphotericin B is a viable treatment option for histoplasmic chorioretinitis.
  • Prompt treatment is crucial to preserve vision in patients with this condition.